KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Change in Inventory (2016 - 2025)

Johnson & Johnson's Change in Inventory history spans 17 years, with the latest figure at $46.0 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 48.89% year-over-year to $46.0 million; the TTM value through Dec 2025 reached $1.5 billion, up 28.55%, while the annual FY2025 figure was $1.5 billion, 28.55% up from the prior year.
  • Change in Inventory for Q4 2025 was $46.0 million at Johnson & Johnson, down from $748.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.3 billion in Q1 2023 and bottomed at -$519.0 million in Q1 2021.
  • The 5-year median for Change in Inventory is $354.0 million (2021), against an average of $361.6 million.
  • The largest YoY upside for Change in Inventory was 337.11% in 2021 against a maximum downside of 253.06% in 2021.
  • A 5-year view of Change in Inventory shows it stood at $360.0 million in 2021, then surged by 66.67% to $600.0 million in 2022, then crashed by 120.67% to -$124.0 million in 2023, then surged by 172.58% to $90.0 million in 2024, then plummeted by 48.89% to $46.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Change in Inventory are $46.0 million (Q4 2025), $748.0 million (Q3 2025), and $510.0 million (Q2 2025).